Document is current
Any future updates will be listed below
-
Authors
Bayou, Nadia
Henretta, Sarah
Munoz-Arcos, Laura
Molteni, Elisabetta
Gianni, Caterina
Serafini, Mara Serena
Nicolò, Eleonora
Pontolillo, Letizia
Pasto, Brenno
Gaudio, Hunter Andrew
Manai, Maroua
Afghan, Muhammad Maaz Khan
Manohar, Jyothi
Elemento, Olivier
Andreopoulou, Eleni
Cristofanilli, Massimo
Reduzzi, Carolina
-
Funding
Funding for this research was provided by:
National Institutes of Health (T35EB006732-17)
ASCO
Meyer Cancer Center
- License Information
-
More Information
Article History
Received: 8 July 2025
Accepted: 16 October 2025
First Online: 24 December 2025
Declarations
:
: The study protocol was approved by the Institutional Review Board of Weill Cornell Medicine (IRB# 1603017108), and written informed consent was obtained from all participants. The research adhered to the ethical standards of the institutional and national research committees, as well as the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All methods were conducted in accordance with relevant guidelines and regulations.
: M.C. and C.R. received research support from Menarini Silicon Biosystems, ANGLE, Tethis spa, Qiagen and Biorad which is not related to the work included in this manuscript. Menarini Silicon Biosystems ANGLE, Tethis spa, Qiagen and Biorad did not take part in the conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript.M.C. reports grants and personal fees from Menarini.M.C., E.N. and C.R. report affiliation with Precision Medicine Action for Cancer (PMAC) (board of director), and with the International Society of Liquid Biopsy (ISLB).
